Downes, M, Algaba, F, Allory, Y, Amin, M, Cheng, L, Desai, S, Eckstein, M, Hartmann, A, Lajkosz, K, Lopez-Beltran, A, Oxley, J, Paner, G, Samaratunga, H, Shen, S, van Montfoort, M, Warrick, J, Williamson, S, Wobker, S, van der Kwast, T. Inter-observer Reproducibility of a Three-Tier Grading System of Papillary Non- Muscle Invasive Urothelial Carcinoma: An International Uropathology Study. LABORATORY INVESTIGATION. 2024; 104(3)DOI:. PMID:. IF:4.200(Q1/1D).

Vilaseca, A, Jayram, G, Raventos, C, Shore, ND, Zainfeld, D, Kang, TW, Ku, JH, Meeks, J, Faba, OR, Roghmann, F, Daneshmand, S, Beeharry, N, Cost, CR, Kalota, A, Lauring, J, Peterson, MR, Quiroz, MQ, Stone, NL, Zhu, W, Gurrero-Ramos, F. First safety and efficacy results of the TAR-210 erdafitinib intravesical delivery system in patients with non-muscle-invasive bladder cancer with select FGFR alterations. EUROPEAN UROLOGY. 2024; 85DOI:. PMID:. IF:25.200(Q1/1D).

Henriquez, JDS, Krajewski, W, González-Padilla, D, Taborda, J, Andrzej, T, Aumatell, JL, Rodrigo, E, Moschini, M, Cano-Velasco, J, Gallioli, A, D Andrea, D, Pilcher, R, Afferi, L, Del Giudice, F, Albisinni, S, Soria, F, Laura, M, Szydelko, T, Burgos, JB, Gonzalez, AS, Medina, AA, Dos Santos, VG, Cidre, MNJ, Revilla, FJB. Is there a role for Bacillus Calmette-Guerin in very high-risk non-muscle invasive bladder carcinoma? Multicenter analysis of oncological outcomes and risk dynamics. EUROPEAN UROLOGY. 2024; 85DOI:. PMID:. IF:25.200(Q1/1D).

Gallioli, A, Uleri, A, Mertens, L, Tedde, A, Moschini, M, Del Giudie, F, Soria, F, Laukhtina, E, Daniel, SJ, Krajewski, W, D'Andrea, D, Mari, A, Marcq, G, Mori, K, Teoh, J, Afferi, L, Basile, G, Territo, A, Sanguedolce, F, Breda, A, Pradere, B. Oncologic outcomes of endoscopic management of upper tract urothelial carcinoma: A systematic review and pooled analysis from the EAU-YAU Urothelial Working Group. EUROPEAN UROLOGY. 2024; 85DOI:. PMID:. IF:25.200(Q1/1D).

Campi, R, Pecoraro, A, Gallioli, A, Territo, A, Basile, G, Berlin, C, Etcheverry, B, Musquera, M, Vangeneugden, J, Orteved, M, Zeuschner, P, Volpe, A, Garcia-Baquero, R, Kocak, B, Idu, M, Fornara, P, Rohrsted, M, Alcaraz, A, Doumerc, N, Vigues, F, Decaestecker, K, Serni, S, Breda, A. Perioperative surgical complications in robot-assisted vs. pure laparoscopic living donor nephrectomy: A European Robotic Urology Section (ERUS) RAKT working group study. EUROPEAN UROLOGY. 2024; 85DOI:. PMID:. IF:25.200(Q1/1D).

Contieri, R, Beijert,, Martini, A, Camperat, EM, Hernandez,, Bruins, HM, Dominguez-Escrig, JL, Liedberg, F, Masson-Lecomte, A, Cohen, D, Mostafid, H, Shariat, SF, Roupret, M, Pradere, B, Zigeuner, R, Soria, F, Soukup,, Redorta, JP, Capoun, O, Burger, M, Gontero, P, Sylvester, R, Mertens, L, Van Rhijn, BWG. Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer. EUROPEAN UROLOGY. 2024; 85DOI:. PMID:. IF:25.200(Q1/1D).

De Angelis, M, Soria, F, Pradere, B, Afferi, L, Montorsi, F, Briganti, A, Shariat, S, Wiklund, P, D'Andrea, D, Albissini, S, Mari, A, Del Giudice, F, Krajewski, W, Laukhtina, E, Teoh, JYC, Mori, K, Mertens, LS, Gallioli, A, Pichler, R, Cimadamore, A, Moschini, M. Risk of upper urinary tract dissemination in cT3 bladder cancer patients treated with Double J stent versus nephrostomy tube prior to radical cystectomy. EUROPEAN UROLOGY. 2024; 85DOI:. PMID:. IF:25.200(Q1/1D).

Bravi, CA, Tappero, S, Dell'Oglio, P, Campi, R, Bertolo, R, Da Pozzo, LF, Simone, G, Suardi, N, Schiavina, R, Bensalah, K, Canda, E, Zhang, X, Terrone, C, Shariat, S, Porpiglia, F, Antonelli, A, Kaouk, J, Badani, K, Minervini, A, Derweesh, I, Breda, A, Mottrie, A, Montorsi, F, Larcher, A. Surgical experience and functional outcomes after laparoscopic and robot-assisted partial nephrectomy: Results from a multi-institutional collaboration. EUROPEAN UROLOGY. 2024; 85DOI:. PMID:. IF:25.200(Q1/1D).